Literature DB >> 220283

In vitro suppression of serum elastase-inhibitory capacity by reactive oxygen species generated by phagocytosing polymorphonuclear leukocytes.

H Carp, A Janoff.   

Abstract

Human polymorphonuclear leukocytes (PMN) phagocytosing opsonized antigen-antibody complexes, produce dialyzable species of activated oxygen which are capable of partially suppressing the elastase-inhibiting capacity (EIC) of whole human serum or purified human alpha1-proteinase inhibitor. Serum EIC was partially protially protected by superoxide dismutase, catalase, or mannitol, suggesting that hydroxyl radical, formed by interaction of superoxide radical and hydrogen peroxide, might be responsible for this effect. NaN3 also partly protected EIC, implicating myeloperoxidase-mediated reactions as well. An artificial superoxide rradical-generating system, involving xanthine and xanthine-oxidase, could be substituted for phagocytosing PMN with resultant EIC suppression. These results are consistent with previous demonstrations of the release of potent oxidants by stimulated PMN, as well as earlier studies from our laboratory showing sensitivity of alpha1-proteinase inhibitor to inactivation by oxidants. Oxidative inactivation of proteinase inhibitors in the microenvironment of PMN accumulating at sites of inflammation may allow proteases released from these cells to more readily damage adjacent connective tissue structures.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 220283      PMCID: PMC372016          DOI: 10.1172/JCI109364

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  10 in total

1.  Possible mechanisms of emphysema in smokers. In vitro suppression of serum elastase-inhibitory capacity by fresh cigarette smoke and its prevention by antioxidants.

Authors:  H Carp; A Janoff
Journal:  Am Rev Respir Dis       Date:  1978-09

2.  Free radicals and inflammation. Protection of phagocytosine leukocytes by superoxide dismutase.

Authors:  M L Salin; J M McCord
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

3.  The role of superoxide anion generation in phagocytic bactericidal activity. Studies with normal and chronic granulomatous disease leukocytes.

Authors:  R B Johnston; B B Keele; H P Misra; J E Lehmeyer; L S Webb; R L Baehner; K V RaJagopalan
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

4.  A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase.

Authors:  R F BEERS; I W SIZER
Journal:  J Biol Chem       Date:  1952-03       Impact factor: 5.157

5.  Superoxide-dependent production of hydroxyl radical catalyzed by iron-EDTA complex.

Authors:  J M McCord; E D Day
Journal:  FEBS Lett       Date:  1978-02-01       Impact factor: 4.124

6.  Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein).

Authors:  J M McCord; I Fridovich
Journal:  J Biol Chem       Date:  1969-11-25       Impact factor: 5.157

7.  The role of lysosomal elastase in the digestion of Escherichia coli proteins by human polymorphonuclear leukocytes: experiments with living leukocytes.

Authors:  J Blondin; A Janoff
Journal:  J Clin Invest       Date:  1976-10       Impact factor: 14.808

8.  Free radicals and inflammation: protection of synovial fluid by superoxide dismutase.

Authors:  J M McCord
Journal:  Science       Date:  1974-08-09       Impact factor: 47.728

9.  Human granulocyte generation of hydroxyl radical.

Authors:  S J Weiss; P K Rustagi; A F LoBuglio
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

10.  Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes.

Authors:  A Janoff; J Scherer
Journal:  J Exp Med       Date:  1968-11-01       Impact factor: 14.307

  10 in total
  64 in total

1.  Comparative properties of three functionally different but structurally related serpin variants from horse plasma.

Authors:  J Potempa; J K Wunderlich; J Travis
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

Review 2.  Oxygen free radicals, inflammation, and synovitis: and synovitis: the current status.

Authors:  P Merry; P G Winyard; C J Morris; M Grootveld; D R Blake
Journal:  Ann Rheum Dis       Date:  1989-10       Impact factor: 19.103

3.  Inhibition of neutrophil oxidative metabolism by nimesulide.

Authors:  F Capsoni; E Venegoni; F Minonzio; A M Ongari; V Maresca; C Zanussi
Journal:  Agents Actions       Date:  1987-06

Review 4.  Mechanisms of oxidant-induced changes in erythrocytes.

Authors:  J R Hatherill; G O Till; P A Ward
Journal:  Agents Actions       Date:  1991-03

5.  Protein degradation following treatment with hydrogen peroxide.

Authors:  S E Fligiel; E C Lee; J P McCoy; K J Johnson; J Varani
Journal:  Am J Pathol       Date:  1984-06       Impact factor: 4.307

6.  Presence, activities, and molecular forms of cathepsin G, elastase, alpha 1-antitrypsin, and alpha 1-antichymotrypsin in bronchiectasis.

Authors:  R Sepper; Y T Konttinen; T Ingman; T Sorsa
Journal:  J Clin Immunol       Date:  1995-01       Impact factor: 8.317

7.  Endothelial cell cytotoxicity in inflammatory vascular diseases--the possible role of oxidised lipoproteins.

Authors:  D R Blake; P Winyard; D G Scott; S Brailsford; A Blann; J Lunec
Journal:  Ann Rheum Dis       Date:  1985-03       Impact factor: 19.103

8.  Increased release of free oxygen radicals by phagocytosing and nonphagocytosing cells from patients with active pulmonary sarcoidosis as revealed by luminol-dependent chemiluminescence.

Authors:  J Barth; P Entzian; W Petermann
Journal:  Klin Wochenschr       Date:  1988-04-01

9.  Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease.

Authors:  Y R Mahida; K C Wu; D P Jewell
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

10.  Lung injury induced by leukocytic proteases.

Authors:  A Janoff; R White; H Carp; S Harel; R Dearing; D Lee
Journal:  Am J Pathol       Date:  1979-10       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.